NAICS Code 325414 – Biological Product (except Diagnostic) Manufacturing
Official 6-digit NAICS national industry U.S. Census Bureau NAICS 2022
At a glance
Available companies
More specific segments
Get counts, pricing and a free sample
Industry examples
Census industry examples, shown as published.
- Agar culture media manufacturing
- Aggressins (except in-vitro) manufacturing
- Allergenic extracts (except diagnostic substances) manufacturing
- Allergens manufacturing
- Antigens manufacturing
- Antiserums manufacturing
- Antitoxins manufacturing
- Antivenoms manufacturing
- Bacterial vaccines manufacturing
- Bacterins (i.e., bacterial vaccines) manufacturing
Show all industry examples
- Blood derivatives manufacturing
- Blood fractions manufacturing
- Cholera serums manufacturing
- Culture media manufacturing
- Gene therapy preparations manufacturing
- Hematology products (except diagnostic substances) manufacturing
- Plasmas manufacturing
- Serums (except diagnostic substances) manufacturing
- Toxoids (e.g., diphtheria, tetanus) manufacturing
- Tuberculin (i.e., tuberculo-protein derived) manufacturing
- Vaccines (i.e., bacterial, virus) manufacturing
- Virus vaccines manufacturing
Official definition
This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).
Source: U.S. Census Bureau, NAICS 2022
Need help identifying the right NAICS code for your business? Our classification team can review your activities and recommend the most appropriate classification. Get expert assistance →
Business Lists & Company Data for NAICS 325414 - Biological Product (except Diagnostic) Manufacturing
Request a free sample to review the data before buying.
Showing: United States | All states
See which companies you could reach
Get a free sample of matching companies, with locations, contacts, and more.
✓ Free sample · ✓ Pay only if you order · ✓ No obligation
Short request form · takes about 30 seconds
What your sample looks like
Preview · details masked| Company | Contact & title | Website | Phone | Employees |
|---|---|---|---|---|
| Agios Pharmaceuticals Inc Cambridge, MA | ||||
| FibroGen Inc San Francisco, CA | ||||
| Immunomedics Inc Morris Plains, NJ |
-
Agios Pharmaceuticals Inc · Cambridge, MA
Contact Website Phone Employees -
FibroGen Inc · San Francisco, CA
Contact Website Phone Employees
- Company
- Address
- Phone
- Website
- Contact name & title
- Business email
- Employees
- Sales volume
- SIC & NAICS
Includes: company, address, phone, website, contacts, emails, employees, sales volume, SIC & NAICS.
✓ Website-reviewed data included with U.S. lists · How we review →
Need several industries? Build a multi-industry list →
Already have a customer or prospect list?
What's included in a business list? Data fields, contacts, classifications, and delivery options.
A delivered list can include company name, address, phone, website, NAICS and SIC codes, employee size, and sales volume. Contact name, title, and business email are available on U.S. records when we have them. Field availability varies by record, and Canadian deliveries do not include business email addresses.
How are these company counts verified? Data sources, verification process, and count methodology.
Counts are SICCODE.com business locations available for purchase, not government census totals. Headquarters and branches are counted separately, and each location is classified by its primary SIC industry. Counts refresh when you change the country or state filter on this page.
More specific segments in NAICS 325414
Segments let you target only the companies you need. Add one or more to your list to get pricing and a free sample.
524 U.S. companies across 4 segments · Segment codes are 8-digit commercial segments that extend the official 6-digit NAICS code. They are not official Census NAICS codes.
| Code | Segment | U.S. companies | Build your list |
|---|---|---|---|
| 325414-01 | Biological Products (Manufacturing) | 487 487 companies | |
| 325414-02 | Biological Specimens (Manufacturing) | 15 15 companies | |
| 325414-03 | Fruit Pollens (Manufacturing) | ||
| 325414-04 | Serums & Vaccines (Manufacturing) | 22 22 companies |
Combine segments for a more targeted list. Free sample before you buy.
Example companies
See how SICCODE.com evaluates businesses using documented activities and official definitions. Select a company to review its classification and the reasoning behind it.
524 verified U.S. companies
- Viveve Medical Inc Englewood, CO View classification →
- Bioreclamation Inc Westbury, NY View classification →
- Synbiotics Corp Kansas City, MO View classification →
- Applied Genetics Technologies Corp Alachua, FL View classification →
- Vitro Diagnostics Inc Golden, CO View classification →
- Life Technologies Corp Frederick, MD View classification →
- Martek Biosciences Corp Columbia, MD View classification →
- Merck Animal Health Millsboro, DE View classification →
Key facts
- Code
- 325414
- Classification level
- Official 6-digit NAICS national industry
- Official source
- U.S. Census Bureau · NAICS 2022
- SBA size standard
- 1,250 employees
SBA size standard effective March 17, 2023. Source: U.S. Small Business Administration Table of Size Standards →
Industry statistics
2022 Economic Census
- Establishments
- 431
- Employees
- 70,460
- Annual payroll
- $7,748,345,000
- Sales, value of shipments, or revenue
- $47,322,287,000
Why do company counts differ?
The U.S. Economic Census counts establishments with paid employees that operated during the census year, including businesses that may have since closed. Its industry classifications draw on business-reported information and government records. SICCODE.com's counts reflect verified business records currently available for purchase, with classifications based on documented business activities. Differences in reporting periods, database coverage, classification methods and verification criteria mean the totals may differ.
2025 International Trade
- U.S. imports
- $43,153,838,237
- U.S. exports
- $57,267,297,535
- Trade balance
- $14,113,459,298
Official commodity description: Biological Products (exc Diagnostic)
Trade surplus partners are countries where the value of U.S. exports exceeds U.S. imports. Trade deficit partners are countries where the value of U.S. imports exceeds U.S. exports.
Top import origins
| Ireland | $10,533,588,003 |
| Belgium | $4,864,455,796 |
| France | $4,106,590,362 |
| Germany | $3,765,979,570 |
| Korea, South | $3,325,547,060 |
| Switzerland | $2,617,273,859 |
| Austria | $2,505,038,511 |
| Singapore | $2,419,400,852 |
| Italy | $2,086,030,528 |
| United Kingdom | $1,616,031,479 |
Top export destinations
| Netherlands | $6,821,686,014 |
| China | $6,696,189,537 |
| Germany | $6,163,056,214 |
| Belgium | $4,383,061,549 |
| Ireland | $4,154,053,541 |
| Japan | $3,946,502,362 |
| Switzerland | $2,615,802,209 |
| Austria | $2,430,659,847 |
| Canada | $2,217,061,935 |
| Italy | $2,151,629,792 |
Trade surplus partners
| Netherlands | $6,604,618,839 |
| China | $6,451,951,679 |
| Japan | $3,825,607,286 |
| Germany | $2,397,076,644 |
| Canada | $1,662,407,075 |
| Brazil | $1,460,781,430 |
| Mexico | $1,220,301,003 |
| Turkey | $1,038,528,664 |
| Spain | $743,052,764 |
| Australia | $620,680,238 |
Trade deficit partners
| Ireland | -$6,379,534,462 |
| France | -$2,828,206,465 |
| Korea, South | -$2,487,681,692 |
| Singapore | -$2,067,645,593 |
| United Kingdom | -$493,689,784 |
| Belgium | -$481,394,247 |
| Slovenia | -$247,527,635 |
| Denmark | -$236,021,020 |
| Sweden | -$195,255,788 |
| Croatia | -$122,567,366 |
Historical statistics
2017 Economic Census and 2018 International Trade
2017 Economic Census
- Establishments (2017)
- 686
- Paid employees (2017)
- 44,790
- Revenue (2017)
- $30,497,746,000
- Annual payroll (2017)
- $4,168,627,000
2018 International Trade
- U.S. imports (2018)
- $36,877,019,615
- U.S. exports (2018)
- $23,092,347,554
- Balance of trade (2018)
- -$13,784,672,061
Official commodity description: Biological Products (exc Diagnostic)
Trade surplus partners are countries where the value of U.S. exports exceeds U.S. imports. Trade deficit partners are countries where the value of U.S. imports exceeds U.S. exports.
Top import origins
| Ireland | $13,431,380,812 |
| Germany | $6,145,980,368 |
| Korea, South | $2,638,402,421 |
| Belgium | $2,268,676,507 |
| Singapore | $2,201,539,996 |
Top export destinations
| Netherlands | $2,967,912,754 |
| Italy | $2,503,927,996 |
| Germany | $2,137,856,820 |
| Belgium | $2,014,809,189 |
| Japan | $1,670,399,325 |
Trade surplus partners
| Netherlands | $1,676,586,938 |
| Italy | $1,568,461,034 |
| China | $889,880,647 |
| Japan | $876,896,318 |
| Canada | $534,561,830 |
Trade deficit partners
| Ireland | -$12,244,655,512 |
| Germany | -$4,008,123,548 |
| Korea, South | -$2,345,381,687 |
| Singapore | -$2,057,851,607 |
| Switzerland | -$527,118,777 |
Cross-references
- Manufacturing in-vitro diagnostic substances are classified in U.S. NAICS Code 325413 - In-Vitro Diagnostic Substance Manufacturing
- Manufacturing pharmaceutical preparations (except biological and in-vitro diagnostic substances) are classified in U.S. NAICS Code 325412 - Pharmaceutical Preparation Manufacturing
NAICS classification hierarchy
Five official Census levels, from sector to national industry, plus a commercial extended level.
-
National industry 325414 Biological Product (except Diagnostic) Manufacturing
One example classification path is shown. Other branches may exist. Extended 8-digit codes are commercial segments, not official Census NAICS codes.
Related classifications
Correspondences in SIC, ISIC and NACE Rev. 2.1. These mappings do not replace the official Census definition.
| System | Code | Title |
|---|---|---|
| NAICS This page | 325414 | Biological Product (except Diagnostic) Manufacturing |
| SIC | 2836 | Biological Products, except Diagnostic Substances Biological Products, except Diagnostic Substances |
| ISIC Rev. 4 | 2100 | Manufacture Of Pharmaceuticals, Medicinal Chemical And Botanical Products Manufacture Of Pharmaceuticals, Medicinal Chemical And Botanical Products |
| NACE Rev. 2.1 (via ISIC 2100) | 21.10 | Manufacture of basic pharmaceutical products Manufacture of basic pharmaceutical products |
| NACE Rev. 2.1 (via ISIC 2100) | 21.20 | Manufacture of pharmaceutical preparations Manufacture of pharmaceutical preparations |
Source: Eurostat, NACE Rev. 2.1 to ISIC Rev. 5 correspondence; United Nations Statistics Division, ISIC Rev. 4 to ISIC Rev. 5 correspondence table.
Sources
-
Official classification source U.S. Census Bureau.
North American Industry Classification System (2022), NAICS 325414. U.S. Census Bureau → -
SICCODE.com commercial data Company-record counts, coverage, and related commercial data are maintained by SICCODE.com. Methodology →
SICCODE.com is an independent publisher. Official NAICS titles and definitions come from the U.S. Census Bureau. Commercial database counts are SICCODE.com records.
About this classification
This page combines the official U.S. Census Bureau NAICS definition with classification crosswalks and SICCODE.com commercial data. Classifications are reviewed regularly by the Classification Review Team.